The Drug Enforcement Administration is issuing a notice of intent to temporarily schedule the opioids mitragynine and 7-hydroxymitragynine, which are the main active constituents of the plant kratom, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of these opioids into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety.
Randox Toxicology exclusively provides an ELISA test for Mitragynine (Kratom). By developing our own in house antibodies this provides excellent intra and inter assay precision typically <10% CV. Offering highly sensitive accurate detection of drugs of abuse and drug metabolites with excellent correlation with GC/LCMS.
Our Mitragynine (Kratom) ELISA test is the only viable method for detecting this scheduled I drug in your laboratory.